{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:38:50Z","timestamp":1791333530711,"version":"4.3.1"},"reference-count":47,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T00:00:00Z","timestamp":1433376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"National Institute of Population Medical Genetics","award":["(Grant CNPq 573993\/2008-4)"],"award-info":[{"award-number":["(Grant CNPq 573993\/2008-4)"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Birth Defects Research"],"published-print":{"date-parts":[[2015,9]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Thalidomide is a known teratogen and it is estimated that more than ten thousand babies were affected by thalidomide embryopathy (TE), which is characterized mainly by limb defects, but can involve many organs and systems. Most people with TE were only evaluated at birth and it is not well established if thalidomide exposure during embryonic development leads to later effects. We analyzed the clinical history of adults with TE to better understand this gap in the clinical findings of TE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Brazilian individuals with TE were invited to answer a clinical questionnaire which considered family history, social information, medical history, and current clinical and psychological health status. A clinical examination was also performed, including on the infant subjects to evaluate congenital anomalies. The characterization of the features was analyzed using descriptive statistics and Chi\u2010square or Fisher's exact test.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The congenital anomalies caused by thalidomide were reviewed in 28 Brazilian individuals, and the questionnaire was applied to the 23 adult subjects with TE (aged 19 to 55). Progressive deafness and dental loss were reported. From the comparison of TE individuals with the general Brazilian population, the early onset of cardiovascular diseases (<jats:italic>p<\/jats:italic>\u2009=\u20090.009) and a higher frequency of psychological disorders (<jats:italic>p<\/jats:italic>\u2009=\u20090.011) were observed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Although there is no sufficient evidence that thalidomide exposure caused or worsened the described events, this approach helps to better understand the TE phenotype, improves the clinical diagnosis, and can lead to adequate health support for these individuals. Birth Defects Research (Part A) 103:794\u2013803, 2015. \u00a9 2015 Wiley Periodicals, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/bdra.23376","type":"journal-article","created":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T16:36:48Z","timestamp":1433435808000},"page":"794-803","source":"Crossref","is-referenced-by-count":32,"title":["Thalidomide embryopathy: Follow\u2010up of cases born between 1959 and 2010"],"prefix":"10.1002","volume":"103","author":[{"given":"Thayne Woycinck","family":"Kowalski","sequence":"first","affiliation":[{"name":"PPGBM (Programa de P\u00f3s Gradua\u00e7\u00e3o em Gen\u00e9tica e Biologia Molecular) Universidade Federal do Rio Grande do Sul Porto Alegre Brazil"},{"name":"National Institute of Population Medical Genetics, INAGEMP Porto Alegre Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa Vieira","family":"Sanseverino","sequence":"additional","affiliation":[{"name":"PPGBM (Programa de P\u00f3s Gradua\u00e7\u00e3o em Gen\u00e9tica e Biologia Molecular) Universidade Federal do Rio Grande do Sul Porto Alegre Brazil"},{"name":"National Institute of Population Medical Genetics, INAGEMP Porto Alegre Brazil"},{"name":"Teratogen Information Service, Medical Genetics Service, Hospital de Cl\u00ednicas de Porto Alegre  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Schuler\u2010Faccini","sequence":"additional","affiliation":[{"name":"PPGBM (Programa de P\u00f3s Gradua\u00e7\u00e3o em Gen\u00e9tica e Biologia Molecular) Universidade Federal do Rio Grande do Sul Porto Alegre Brazil"},{"name":"National Institute of Population Medical Genetics, INAGEMP Porto Alegre Brazil"},{"name":"Teratogen Information Service, Medical Genetics Service, Hospital de Cl\u00ednicas de Porto Alegre  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Sales Luiz","family":"Vianna","sequence":"additional","affiliation":[{"name":"PPGBM (Programa de P\u00f3s Gradua\u00e7\u00e3o em Gen\u00e9tica e Biologia Molecular) Universidade Federal do Rio Grande do Sul Porto Alegre Brazil"},{"name":"National Institute of Population Medical Genetics, INAGEMP Porto Alegre Brazil"},{"name":"Teratogen Information Service, Medical Genetics Service, Hospital de Cl\u00ednicas de Porto Alegre  Brazil"},{"name":"Programa de P\u00f3s Gradua\u00e7\u00e3o em Epidemiologia Universidade Federal do Rio Grande do Sul Porto Alegre Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,6,4]]},"reference":[{"key":"e_1_2_6_2_1","unstructured":"ANVISA ANdVS(2003).Law 10651\/03. Bras\u00edlia Brazil: DOU Diario Oficial da Uniao. Available at:http:\/\/pfdc.pgr.mpf.gov.br\/atuacao\u2010e\u2010conteudos\u2010deapoio\/legislacao\/saude\/leis\/lei_10651_03. Accessed August 4 2014."},{"key":"e_1_2_6_3_1","volume-title":"RDC n\u00ba 11, Mar\u00e7o\/2011","author":"ANVISA","year":"2011"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0911531107"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.3109\/00016356609026116"},{"key":"e_1_2_6_6_1","volume-title":"Basic data indicators","author":"Brazilian Health Ministry","year":"2012"},{"key":"e_1_2_6_7_1","volume-title":"PNAD questionnaire","author":"Brazilian Institute of Geography and Statistics (IBGE)","year":"2003"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9926(199612)54:6<273::AID-TERA1>3.0.CO;2-#"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.9.4082"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2012.03.011"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/00016350802307638"},{"issue":"2","key":"e_1_2_6_12_1","first-page":"H2319","article-title":"Limb reduction defects in endothelial nitric oxide synthase\u2010deficient mice","volume":"275","author":"Gregg AR","year":"1998","journal-title":"Am J Physiol"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-014-3115-8"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1089\/152308604771978291"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000146196.01316.A2"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12152"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1177319"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12005"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/wdev.63"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2005.03344.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420380303"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.niox.2012.01.003"},{"key":"e_1_2_6_23_1","first-page":"47","article-title":"Ocular motility in thalidomide embryopathy","volume":"28","author":"Miller MT","year":"1991","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y"},{"key":"e_1_2_6_25_1","first-page":"100","article-title":"Congenital aberrant tearing: a re\u2010look","volume":"106","author":"Miller MT","year":"2008","journal-title":"Trans Am Ophthalmol Soc"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.6.1675"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0095-5108(18)30810-8"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0102-311X1999000100011"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2005.11.007"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2011.02.006"},{"key":"e_1_2_6_31_1","first-page":"449","article-title":"A trag\u00e9dia da Talidomida e o advento da teratologia experimental","volume":"17","author":"Saldanha","year":"1994","journal-title":"Rev Bras Genet"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.173.3.699"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0001566000007819"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20384"},{"key":"e_1_2_6_35_1","first-page":"208","volume-title":"Psychotropic drugs. Chemical induced birth defects","author":"Shardein J","year":"1993"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt196563303"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep00679"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215112001429"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.29.10.716"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1960.tb01217.x"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.1993.tb04997.x"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1994.tb11856.x"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/tera.10083"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10266-011-0052-z"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021735"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.niox.2013.09.002"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCD.0b013e32835ffc58"},{"key":"e_1_2_6_48_1","volume-title":"Thalidomide embryopathy: report of a meeting of experts","author":"WHO","year":"2014"}],"container-title":["Birth Defects Research Part A: Clinical and Molecular Teratology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbdra.23376","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbdra.23376","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bdra.23376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T19:01:57Z","timestamp":1696618917000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/bdra.23376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,4]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.1002\/bdra.23376"],"URL":"https:\/\/doi.org\/10.1002\/bdra.23376","archive":["Portico"],"relation":{},"ISSN":["1542-0752","1542-0760"],"issn-type":[{"value":"1542-0752","type":"print"},{"value":"1542-0760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,4]]}}}